‘Wow.’ In A First, FDA Requests An Opioid Be Pulled From The Market – Forbes


Forbes

‘Wow.’ In A First, FDA Requests An Opioid Be Pulled From The Market
Forbes
In a dramatic first, the Food and Drug Administration is requesting that a manufacturer, Endo Pharmaceuticals, remove an opioid drug, Opana ER, from the market because of its potential for causing abuse. “We are facing an opioid epidemic – a public
FDA requests removal of Opana ER for risks related to abuseFDA.gov
US FDA asks Endo to withdraw Opana ER opioid; shares fallReuters
FDA Seeks to Pull Pain Pill Off Market, Citing Risk of AbuseBloomberg
Washington Examiner –Washington Post –MedPage Today –Business Insider
all 23 news articles »

Source

READ ---  Hack of Wall St. regulator rattles investors, lawmakers